NAD+ precursor treatment prevents cardiomyopathybut disrupts erythroid maturation in mitochondrial progeria
Nahid Akthar Khan, Kati J. Ahlqvist, Swagat Pradhan…·Anu Suomalainen
This study shows that NAD+ precursor treatment improves cardiac function but worsens erythroid maturation in mitochondrial progeria, highlighting tissue-specific effects of NAD+ boosting.